Announcements Trials
Browse Landscape

Status

Active not recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Tuberous Sclerosis 1Seizures 1Neoplasms 1Lennox Gastaut Syndrome 1Epilepsies, Myoclonic 1

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 49Specimen Handling 29Observation 15Radiotherapy 14Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 11Interviews as Topic 11Data Collection 11Drug Therapy 9darolutamide 8Biopsy 8palbociclib 7Watchful Waiting 7Tomography, X-Ray Computed 7Standard of Care 7ribociclib 6Magnetic Resonance Imaging 6Bevacizumab 6trastuzumab deruxtecan 5Ultrasonography 5Restraint, Physical 5Radiofrequency Ablation 5Patient Reported Outcome Measures 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Mass Screening 5Genetic Testing 5Breath Tests 5enzalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Cannabidiol × 90 days × Clear all
NCT05485831 2026-06-03

EpiTALY

Jazz Pharmaceuticals

Active not recruiting
111 enrolled

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05836857 2026-04-16

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

M.D. Anderson Cancer Center

Active not recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡